NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/19/2025
Back to search
Official data from USPTO
ACCORD BIOPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
08/19/2025
Trademark type
Combined
Nice classes
5, 36, 41, 44
Filing date
07/31/2024
Registration date
08/19/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/19/2025
Last transaction
08/19/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/01/2022
First use in commerce
04/01/2022
Drawing code
3
Owner type
03
Owner location
Raleigh, NC, US
Examiner
CHANG, KATHERINE S
Law office
M60
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized word "accord" where the "a", "r" and "d" are in dark orange and the "c", "c" and "o" are in dark grey. To the right is the stylized word "BioPharma" where "Bio" is in light grey and "Pharma" is in light orange. Above the "rma" portion of "Pharma" are three hexagons in an arch formation. The first hexagon is light grey, the second is dark grey and the third is dark orange.
Holders and representatives
Holders
Accord Biopharma, Inc.
Representatives
Michele K. Robichaux ODIN LAW AND MEDIA
Technical classification
Nice Classes
Class 5Class 36Class 41Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
A full line of medicated and pharmaceutical preparationspharmaceutical preparations and substances for use by humans for the preventiontreatment and management of cancerautoimmune diseasesimmunological deficiency syndromes in the nature of autoimmune diseasescritical illnesses in the nature of immune system related diseases and disorders
Class 36
Providing insurance information in the form of answers to questions from healthcare providers and patients about medication insurance coverageinsurance reimbursementinsurance payer policies and patient financial assistance; healthcare insurance administration services in the field of benefit verification servicesprior authorization support and informationbilling and claims processing supportclaims appeal support; providing information about healthcare insurancepatient financial assistancepatient insurance reimbursement programs including enrollment requirements
Class 41
Providing online non-downloadable videos featuring information regarding therapies and treatment options in the fields of oncologyimmunologycritical care
Class 44
Providing healthcare and medical information; providing healthcare and medical information in the fields of oncologyimmunologycritical care and biosimilars
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/19/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/01/2025
PUBO
PUBLISHED FOR OPPOSITION
07/01/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/25/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/28/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/26/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/26/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/26/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/24/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/24/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/24/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/24/2025
GNRT
NON-FINAL ACTION E-MAILED
02/24/2025
CNRT
NON-FINAL ACTION WRITTEN
02/24/2025
DOCK
ASSIGNED TO EXAMINER
02/18/2025
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/17/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/17/2025
NWAP
NEW APPLICATION ENTERED
07/31/2024
Continuous trademark protection
Get notified about every new filing that threatens ACCORD BIOPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.